Sanofi Ventures manages over $1.4B in AUM after a $625M capital injection in 2025, investing in biotech and digital health innovation. Since 2012, the fund has deployed over $800M across 75 companies in immunology, rare diseases, neurology, and vaccines.
Auto-detected from Sanofi Ventures's website.
Life science and healthcare consultant with background at L.E.K. consulting and Harvard postdoctoral fellowship.
20+ years healthtech dealmaking and AI scaling experience; founding member of Johnson & Johnson Innovation.
Early-stage biotech investing and transactions expert with background at Atlas Venture and Flagship Ventures.
Healthcare services and digital health investor with four years at RA Capital Management.
Early-stage biotech investor with drug development expertise and board experience at Ysios Capital.
Biotech investor and business development professional with experience at Vertex Pharmaceuticals and RA Capital.
Early-stage biotech investor and company builder with postdoctoral fellowship in Robert Langer's lab at MIT.
Focus and check size from the firm's website. Website reachable as of Aug 2026.
A fit check scores your pitch against their thesis, stage and ticket. An email draft uses their real deals and thesis, not a template.